Stock A007460 APROGEN MEDICINES INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Aprogen Medicines Inc.

Equities

A007460

KR7007460009

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 13/06/2024 am IST 		5-day change 1st Jan Change
1,282 KRW -0.08% Intraday chart for Aprogen Medicines Inc. +7.37% +33.54%
14/05 Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
19/03 Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.
CI
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Aprogen Medicines Inc. announced that it has received KRW 5.5 billion in funding
CI
Aprogen Medicines Inc. announced that it expects to receive KRW 5.5 billion in funding
CI
Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding
CI
Aprogen Medicines Inc. announced that it expects to receive KRW 70 billion in funding
CI
Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.
CI
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.
CI
Aprogen Medicines Inc. completed the acquisition of remaining unknown stake in Aprogen, Inc.
CI
Aprogen Medicines Inc. signed a merger contract to acquire remaining unknown stake in Aprogen, Inc.
CI
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.
CI
Aprogen KIC Inc. announced that it has received KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.
CI
Aprogen KIC Inc. cancelled the acquisition of additional 5.6% stake in Aprogen pharmaceuticals,Inc..
CI
Aprogen KIC Inc. announced that it expects to receive KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.
CI
Aprogen KIC Inc. announced that it has received KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A007460 Stock
  4. News Aprogen Medicines Inc.